Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Cancer Research
|
July 5, 2005
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6
Jose D Debes, Barbara Comuzzi, Lucy J Schmidt, et al.
Oncotarget
|
January 8, 2019
Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase <i>AMACR</i> promoter for the molecular imaging of prostate cancer
Mariya Shapovalova, Julia Davydova, Christine Henzler, et al.
Oncotarget
|
August 27, 2019
Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
Mariya Shapovalova, Julia Davydova, Christine Henzler, et al.
Cell Reports
|
January 23, 2025
CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
Kiel T Tietz, Braedan M McCluskey, Conor R Miller, et al.
Cancer Research
|
November 3, 2012
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
Yingming Li, Siu Chiu Chan, Lucas J Brand, et al.
Nucleic Acids Research
|
April 23, 2019
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities
Evangelia Kounatidou, Sirintra Nakjang, Stuart R C McCracken, et al.
Nature Communications
|
March 6, 2024
Evolving copy number gains promote tumor expansion and bolster mutational diversification
Zicheng Wang, Yunong Xia, Lauren Mills, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 15, 2019
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
Janeen H Trembley, Betsy T Kren, Md J Abedin, et al.
The Prostate
|
February 8, 2013
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants
Laura R Bohrer, Ping Liu, Jian Zhong, et al.
Research Square
|
June 5, 2025
Novel mixed cancer-cell models designed to capture inter-patient tumor heterogeneity for accurate evaluation of drug combinations
Sampreeti Jena, Daniel Kim, Adam M Lee, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Cancer Research
|
July 5, 2005
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6
Jose D Debes, Barbara Comuzzi, Lucy J Schmidt, et al.
Oncotarget
|
January 8, 2019
Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase <i>AMACR</i> promoter for the molecular imaging of prostate cancer
Mariya Shapovalova, Julia Davydova, Christine Henzler, et al.
Oncotarget
|
August 27, 2019
Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
Mariya Shapovalova, Julia Davydova, Christine Henzler, et al.
Cell Reports
|
January 23, 2025
CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
Kiel T Tietz, Braedan M McCluskey, Conor R Miller, et al.
Cancer Research
|
November 3, 2012
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
Yingming Li, Siu Chiu Chan, Lucas J Brand, et al.
Nucleic Acids Research
|
April 23, 2019
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities
Evangelia Kounatidou, Sirintra Nakjang, Stuart R C McCracken, et al.
Nature Communications
|
March 6, 2024
Evolving copy number gains promote tumor expansion and bolster mutational diversification
Zicheng Wang, Yunong Xia, Lauren Mills, et al.
Pharmaceuticals (Basel, Switzerland)
|
June 15, 2019
CK2 Pro-Survival Role in Prostate Cancer Is Mediated via Maintenance and Promotion of Androgen Receptor and NFκB p65 Expression
Janeen H Trembley, Betsy T Kren, Md J Abedin, et al.
The Prostate
|
February 8, 2013
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants
Laura R Bohrer, Ping Liu, Jian Zhong, et al.
Research Square
|
June 5, 2025
Novel mixed cancer-cell models designed to capture inter-patient tumor heterogeneity for accurate evaluation of drug combinations
Sampreeti Jena, Daniel Kim, Adam M Lee, et al.
Page
of 13